Login

Login

Generate password

Change password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Aspira Pathlab & Diagnostics Ltd.

NSE : BSE : 540788 ISIN CODE : INE500C01017Industry : Hospitals & Medical Services

News

  • Aspira Pathlab & Dia - Updation In Contact Details Of The Company Registrar And Share Transfer Agent 22 Apr 2025 | 13:39 | Dion Global

    Updation in Contact Details of the Company Registrar and Share Transfer Agentmore...

  • Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025 16 Apr 2025 | 13:12 | Dion Global

    As of March 2025 18.39% is owned by Indian Promoters and 81.61% by Public. Top four Promoters holding highest number of shares of Aspira Pat...more...

  • Aspira Pathlab & Dia - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 15 Apr 2025 | 13:46 | Dion Global

    Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Aspira Pathlab...more...

  • Aspira Pathlab & Dia - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 15 Apr 2025 | 13:23 | Dion Global

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Aspira P...more...

  • Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 09 Apr 2025 | 16:13 | Dion Global

    Compliance Certificate in accordance with regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 3...more...

  • Aspira Pathlab & Dia - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 08 Apr 2025 | 19:24 | Dion Global

    Announcement as per regulation 30 of the SEBI (LODR) Regulations 2015more...

  • Aspira Pathlab & Dia posts Q3 net profit of Rs 0.38 cr 07 Feb 2025 | 19:12 | Dion Global

    The company reported standalone net profit during the quarter stood at Rs 0.38 crore compared to net loss of Rs 0.74 crore in the previous year quart...more...

  • Aspira Pathlab & Dia - Integrated Filing (Financial) 07 Feb 2025 | 18:11 | Dion Global

    Integrated Filing (Financial) for third quarter and nine months ended December 31 2024more...

  • Aspira Pathlab & Dia - Board Meeting Outcome for For Unaudited Financial Results (Both Standalone & Consolidated) Alongwith L 07 Feb 2025 | 17:31 | Dion Global

    Outcome of the Board Meeting dated February 07 2025\r\nmore...

  • Aspira Pathlab & Dia - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months E 31 Jan 2025 | 13:33 | Dion Global

    Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter ...more...

  • Aspira Pathlab & Dia - Reconstitution Of Audit And Stakeholder Relationship Committee W.E.F February 01, 2025 29 Jan 2025 | 13:48 | Dion Global

    Reconstitution of Audit and Stakeholdership Relationship Committee by appointing Mr. Manas Mengar (DIN:10218206)Independent Director of the Company a...more...

  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Resignation of Director 22 Jan 2025 | 19:16 | Dion Global

    Resignation of Mr. Avinash Chander Mahajan (DIN:00041661) as Non-executive and Independent Director of the Company with the immediate effect.more...

  • Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024 20 Jan 2025 | 13:40 | Dion Global

    As of December 2024 18.55% is owned by Indian Promoters and 81.45% by Public. Top four Promoters holding highest number of shares of Aspira Pathlab &...more...

  • Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 08 Jan 2025 | 14:09 | Dion Global

    Compliance Certificate in accordance with regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ende...more...

  • Aspira Pathlab & Dia - Intimation For Change In The Name Of The Registrar And Share Transfer Agent 02 Jan 2025 | 13:36 | Dion Global

    This is to inform that the name of our Registrar and Share Transfer Agent has been changed from Link Intime India Private Limited to MUFG Intime Indi...more...

  • Aspira Pathlab & Dia - Inauguration Of New Diagnostics Centre At Andheri, Mumbai 02 Dec 2024 | 13:40 | Dion Global

    A new Diagnostics centre named as M/s. Mistry Diagnostics centre has been inaugurated w.e.f today at Andheri Mumbai.more...

  • Aspira Pathlab & Dia posts Q2 net profit of Rs 0.99 cr 12 Nov 2024 | 20:00 | Dion Global

    The company reported standalone net profit during the quarter stood at Rs 0.99 crore compared to net loss of Rs 0.71 crore in the previous year quart...more...

  • Aspira Pathlab & Dia - Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Along With Limited R 12 Nov 2024 | 18:51 | Dion Global

    Unaudited Standalone and Consolidated Financial Results along with Limited Review Report for quarter/half year ended September 2024more...

  • Aspira Pathlab & Dia - Board Meeting Intimation for To Consider And Approve Unaudited Standalone And Consolidated Financial R 29 Oct 2024 | 16:26 | Dion Global

    Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to c...more...

Enter Stock

DOW Jones40280.940.42%
Nasdaq17388.710.03%
S&P 5005536.520.20%
Nikkei 22535839.990.38%
Hang Seng22060.080.40%
Shanghai Composite3287.6-0.02%
Sensex80599.970.48%
NSE Index24370.70.17%
BSE 100LCTMC9015.660.48%
BSE Auto 50358.560.59%
BSE Bharat228450.940.57%
BSE CPSE 3722.360.81%

Commodity

Gold94600-0.68%
Silver96008-1.47%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 85.20(-0.44 %)
GBP/INR 113.43(-0.34 %)
EUR/INR 96.86(-0.27 %)
JPY/INR 0.59(-0.48 %)
CAD/INR 61.63(0.00 %)
HKD/INR 11.03(0.00 %)